Zhuan Liao1, Liang-Hao Hu1, Zhao-Shen Li1, Chang-Jing Zuo2, Li Wang2, Gang Jin3, Duo-Wu Zou1, Zhen-Dong Jin1, Shu-De Li1, Feng Liu4, Jie Chen5, Xian-Bao Zhan1, Jin-Hua Yuan1, Luo-Wei Wang1, Dong Wang1. 1. Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai, China. 2. Department of Radiology, Changhai Hospital, Second Military Medical University, Shanghai, China. 3. Department of Hepato-Pancreato-Biliary Surgery, Changhai Hospital, Second Military Medical University, Shanghai, China. 4. Digestive Endoscopy Center, Changhai Hospital, Second Military Medical University, Shanghai, China. 5. Department of Anesthetists, Changhai Hospital, Second Military Medical University, Shanghai, China.
Abstract
OBJECTIVE: To determine the effect of multidisciplinary team meeting (MDTM) on the success rate and complications of therapeutic endoscopic retrograde cholangiopancreatography (ERCP) for hepato-pancreato-biliary diseases. METHODS: All patients undergoing their first therapeutic ERCP over a 21-month period of time in a tertiary care medical center were included. Generally, patients scheduled for ERCP on Friday, Saturday, Sunday, and Monday were subject to MDTM group, and those on Tuesday, Wednesday, and Thursday were allocated to the control group. For each MDTM case, an MDTM was held on the Tuesday prior to the scheduled ERCP. At the meeting, the cases were discussed by a team consisting of chief physicians, radiologists, endoscopists, anesthetists, and surgeons, and a decision was made on the schedule of ERCP. For control cases, a clinical team of one chief physician and two attending physicians made the decision. RESULTS: From April 2006 to December 2007, 912 and 997 ERCP procedures were allocated to the MDTM and control groups, respectively. There was no significant difference in the baseline characteristics and indications between the two groups. Although the success rates were not significantly different between MDTM and control groups (82.9% vs. 84.8%, P=0.321), MDTM was significantly associated with a decreased overall complication rate of (6.9% vs. 12.0%, p<0.001) and severe complication rate (0.4% vs. 2.5%, p=0.035). CONCLUSIONS: Pre-ERCP MDTM decreases the frequency and severity of ERCP-related complications, with similar success rate, compared to routine practice.
OBJECTIVE: To determine the effect of multidisciplinary team meeting (MDTM) on the success rate and complications of therapeutic endoscopic retrograde cholangiopancreatography (ERCP) for hepato-pancreato-biliary diseases. METHODS: All patients undergoing their first therapeutic ERCP over a 21-month period of time in a tertiary care medical center were included. Generally, patients scheduled for ERCP on Friday, Saturday, Sunday, and Monday were subject to MDTM group, and those on Tuesday, Wednesday, and Thursday were allocated to the control group. For each MDTM case, an MDTM was held on the Tuesday prior to the scheduled ERCP. At the meeting, the cases were discussed by a team consisting of chief physicians, radiologists, endoscopists, anesthetists, and surgeons, and a decision was made on the schedule of ERCP. For control cases, a clinical team of one chief physician and two attending physicians made the decision. RESULTS: From April 2006 to December 2007, 912 and 997 ERCP procedures were allocated to the MDTM and control groups, respectively. There was no significant difference in the baseline characteristics and indications between the two groups. Although the success rates were not significantly different between MDTM and control groups (82.9% vs. 84.8%, P=0.321), MDTM was significantly associated with a decreased overall complication rate of (6.9% vs. 12.0%, p<0.001) and severe complication rate (0.4% vs. 2.5%, p=0.035). CONCLUSIONS: Pre-ERCP MDTM decreases the frequency and severity of ERCP-related complications, with similar success rate, compared to routine practice.
Entities:
Keywords:
complication; endoscopic retrograde cholangiopancreatography; multidisciplinary team meeting; success rate
Authors: Sidney Cohen; Bruce R Bacon; Jesse A Berlin; David Fleischer; Gail A Hecht; Patrick J Loehrer; Alfred E McNair; Michael Mulholland; Nancy J Norton; Linda Rabeneck; David F Ransohoff; Amnon Sonnenberg; Michael W Vannier Journal: Gastrointest Endosc Date: 2002-12 Impact factor: 9.427
Authors: E P Tagge; P R Tarnasky; J Chandler; D U Tagge; C Smith; A Hebra; R H Hawes; P B Cotton; H B Othersen Journal: J Pediatr Surg Date: 1997-02 Impact factor: 2.545
Authors: Matthew D Rutter; Amit Chattree; Jamie A Barbour; Siwan Thomas-Gibson; Pradeep Bhandari; Brian P Saunders; Andrew M Veitch; John Anderson; Bjorn J Rembacken; Maurice B Loughrey; Rupert Pullan; William V Garrett; Gethin Lewis; Sunil Dolwani Journal: Gut Date: 2015-06-23 Impact factor: 23.059